Skip to main content
Log in

Neither guidelines nor symptom-targeted opioids are harmful when withdrawing life-sustaining measures

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rady MY, Verheijde JL (2016) The Canadian guidelines for the withdrawal of life‑sustaining treatment: the role of evidence. Intensive Care Med. doi:10.1007/s00134-016-4372-x

    PubMed  Google Scholar 

  2. Campbell ML, Bizek KS, Thill M (1999) Patient responses during rapid terminal weaning from mechanical ventilation: a prospective study. Crit Care Med 27(1):73–77

    Article  CAS  PubMed  Google Scholar 

  3. Delaney JW, Downar J (2016) How is life support withdrawn in intensive care units: a narrative review. J Crit Care. doi:10.1016/j.jcrc.2016.04.006

  4. Downar J, Delaney JW, Hawryluck L, Kenny L (2016) Guidelines for the withdrawal of life-sustaining measures. Intensive Care Med 42:1003–1017. doi:10.1007/s00134-016-4330-7

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James Downar.

Ethics declarations

Conflicts of interest

None to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Downar, J., Delaney, J., Hawryluck, L. et al. Neither guidelines nor symptom-targeted opioids are harmful when withdrawing life-sustaining measures. Intensive Care Med 42, 1303–1304 (2016). https://doi.org/10.1007/s00134-016-4390-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-016-4390-8

Keywords

Navigation